These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7901453)

  • 21. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
    Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
    Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
    Mechetner EB; Roninson IB
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.
    Sonneveld P; Schoester M; de Leeuw K
    J Clin Oncol; 1994 Aug; 12(8):1584-91. PubMed ID: 7518859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia.
    Svoboda-Beusan I; Kusec R; Bendelja K; Tudoric-Ghemo I; Jaksic B; Pejsa V; Rabatic S; Vitale B
    Haematologica; 2000 Dec; 85(12):1261-7. PubMed ID: 11114132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
    Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
    J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
    Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
    Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
    Center MS
    Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistance mechanisms in chronic lymphocytic leukaemia.
    Consoli U; Santonocito A; Stagno F; Fiumara P; Privitera A; Parisi G; Giustolisi GM; Pavone B; Palumbo GA; Di Raimondo F; Milone G; Guglielmo P; Giustolisi R
    Br J Haematol; 2002 Mar; 116(4):774-80. PubMed ID: 11886380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas.
    Sugawara I; Kodo H; Ohkochi E; Hamada H; Tsuruo T; Mori S
    Br J Cancer; 1989 Oct; 60(4):538-41. PubMed ID: 2572270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.
    Larkin A; Moran E; Alexander D; Clynes M
    Adv Exp Med Biol; 1999; 457():65-70. PubMed ID: 10500781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
    Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
    J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified multiple drug resistance phenotype of Chinese hamster ovary cells selected with X-rays and vincristine versus X-rays only.
    McClean S; Hill BT
    Br J Cancer; 1994 Apr; 69(4):711-6. PubMed ID: 7908216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.
    Sanfilippo O; Ronchi E; De Marco C; Di Fronzo G; Silvestrini R
    Eur J Cancer; 1991; 27(2):155-8. PubMed ID: 1673852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.
    Tóth K; Vaughan MM; Slocum HK; Arredondo MA; Takita H; Baker RM; Rustum YM
    Am J Pathol; 1994 Feb; 144(2):227-36. PubMed ID: 7508682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
    Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
    Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
    Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
    Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
    Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M
    Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of bcl-2 with P-glycoprotein expression in chronic lymphocytic leukaemia and other haematological neoplasms but of neither marker with ex vivo chemosensitivity or patient survival.
    Bosanquet AG; Bell PB; Burlton AR; Amos TA
    Leuk Lymphoma; 1996 Dec; 24(1-2):141-7. PubMed ID: 9049970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.